Dr. Jean-Pierre Lehner is a member of the Board of Directors at AptamiR. He is a cardiologist, and the retired Chief Medical Officer of Sanofi, with previous positions at Roussel, Roussel-UCLAF, and Sanofi Winthrop. Currently, he is CEO of JPL Pharma Consulting and a Board Member of several biotech and R&D companies. Dr. Lehner earned his M.D. at the University of Paris School of Medicine.
Philippe Camus
Mr. Camus is Chairman of the Board of Directors at AptamiR. He also holds the positions of Chairman of the Board at Alcatel-Lucent and Senior Advisor at Evercore Partners. Formerly, he was the CEO of EADS and co-managing partner at Lagardère. He holds degrees from Ecole Normale Supérieure and Institut d’Etudes Politiques de Paris.
Marc Thibonnier, M.D., M.Sc.
- Dr. Thibonnier is the Founder and President of AptamiR Therapeutics, Inc. As a Physician-Scientist, he led a successful career in academic medicine in France and the USA up to the rank of tenured Professor of Medicine and Pharmacology, followed by several years in executive leadership positions at major Pharmaceutical Companies (Bayer Health Care, BMS, and GSK) and two Biotechnology Startup Companies, overseeing cardiovascular and metabolic drugs development from candidate selection to regulatory approval.
- Dr. Thibonnier earned a M.D. degree with High Honors from the Université Pierre et Marie Curie in Paris, France and a M.Sc. in Pharmacology from the University of California, San Francisco where he completed his fellowship in clinical pharmacology. He trained in Endocrinology, Nephrology and Clinical Pharmacology.